New and emerging concepts in the use of denosumab for the treatment of osteoporosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New and emerging concepts in the use of denosumab for the treatment of osteoporosis
Authors
Keywords
-
Journal
Therapeutic Advances in Musculoskeletal Disease
Volume 10, Issue 11, Pages 209-223
Publisher
SAGE Publications
Online
2018-10-23
DOI
10.1177/1759720x18805759
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates
- (2018) Anne M. Horne et al. CALCIFIED TISSUE INTERNATIONAL
- Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis
- (2018) David W Dempster et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
- (2018) Kenneth G Saag et al. Lancet Diabetes & Endocrinology
- Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures
- (2018) Jessica Starr et al. Current Osteoporosis Reports
- Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis
- (2017) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
- (2017) Athanasios D Anastasilakis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM Extension
- (2017) Nelson B Watts et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward
- (2017) Sundeep Khosla et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation
- (2017) Olivier Lamy et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting
- (2017) Arthur N. Lau et al. JOURNAL OF RHEUMATOLOGY
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States
- (2017) Emily Durden et al. Archives of Osteoporosis
- Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis
- (2016) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cancel the denosumab holiday
- (2016) M. R. McClung OSTEOPOROSIS INTERNATIONAL
- Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials
- (2015) Ana Boquete-Castro et al. CLINICAL ORAL IMPLANTS RESEARCH
- The Pathophysiology and Treatment of Osteoporosis
- (2015) Matthew T. Drake et al. CLINICAL THERAPEUTICS
- The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2015) Dennis M. Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial
- (2015) Bente L. Langdahl et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports
- (2015) B. Aubry-Rozier et al. OSTEOPOROSIS INTERNATIONAL
- The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study
- (2015) S. Papapoulos et al. OSTEOPOROSIS INTERNATIONAL
- Rebound-associated vertebral fractures after discontinuation of denosumab—from clinic and biomechanics
- (2015) A. W. Popp et al. OSTEOPOROSIS INTERNATIONAL
- Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review
- (2015) J. Selga et al. OSTEOPOROSIS INTERNATIONAL
- Risk of Hospitalized Infection Among Rheumatoid Arthritis Patients Concurrently Treated With a Biologic Agent and Denosumab
- (2015) Jeffrey R. Curtis et al. Arthritis & Rheumatology
- Atypical fracture of the femur in a patient using denosumab – a case report
- (2014) Jörg Schilcher et al. Acta Orthopaedica
- Atypical femoral fracture in a patient treated with denosumab
- (2014) Kareeann Sok Fun Khow et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?
- (2014) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
- (2014) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Goal-directed treatment of osteoporosis in Europe
- (2014) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Denosumab and atypical femoral fractures
- (2013) Per Aspenberg Acta Orthopaedica
- Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
- (2013) C. Roux et al. BONE
- Goal-directed treatment of osteoporosis
- (2013) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Treat-to-target for Osteoporosis: Is Now the Time?
- (2013) E. Michael Lewiecki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- (2013) Joy N Tsai et al. LANCET
- Denosumab and atypical femur fractures
- (2013) Monica Therese Cating-Cabral et al. MATURITAS
- Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy
- (2013) Chris Recknor et al. OBSTETRICS AND GYNECOLOGY
- SCOPE: a scorecard for osteoporosis in Europe
- (2013) J. A. Kanis et al. Archives of Osteoporosis
- Masthead
- (2012) AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing
- (2012) Silvano Adami et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density
- (2012) Eric Orwoll et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
- (2012) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures
- (2011) Matthew Austin et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension
- (2011) Socrates Papapoulos et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
- (2011) N. B. Watts et al. OSTEOPOROSIS INTERNATIONAL
- Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
- (2011) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies
- (2010) Ian R Reid et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
- (2010) Joel S. Finkelstein et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial
- (2010) Paul D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
- (2009) David L Kendler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab in postmenopausal osteoporosis: what the clinician needs to know
- (2009) E. Michael Lewiecki Therapeutic Advances in Musculoskeletal Disease
- Functions of RANKL/RANK/OPG in bone modeling and remodeling
- (2008) Brendan F. Boyce et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
- (2008) Stanley B. Cohen et al. ARTHRITIS AND RHEUMATISM
- Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
- (2008) Paul D. Miller et al. BONE
- Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial*
- (2008) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
- (2008) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now